Litcius/Paper detail

Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling

Ting Sun, Yunyong Liu, Mengdan Li, Huihui Yu, Haozhe Piao

2020Molecular and Cellular Probes47 citationsDOI

Topics & Concepts

HyperosidePaclitaxelPharmacologyBiologyViability assayApoptosisCancer researchCancer cellCancerMCF-7BiochemistryQuercetinHuman breastGeneticsAntioxidantInflammatory mediators and NSAID effectsCancer Treatment and PharmacologyNatural product bioactivities and synthesis
Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling | Litcius